Sponsor:
University of Ottawa
Code:
NCT01400165
Conditions
Healthy
Eligibility Criteria
Sex: Male
Age: 18 - 50
Healthy Volunteers: Accepted
Interventions
Trazodone
Quetiapine
Pindolol
Blood Collection
Brief summary:
Conditions
Healthy
Study ID
NCT01400165
Start date
Jul, 2011
Status verified date
Jul, 2011
Completion date
Dec, 2011
Anticipated
Primary completion date
Dec, 2011
Anticipated
Eligibility Criteria
Sex: Male
Age: 18 - 50
Healthy Volunteers: Accepted
Enrollment
30 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Treatment
Arms
active comparator: Desyrel/Teva-Trazodone
active comparator: Visken/Teva-Pindolol
active comparator: Seroquel/Teva-Quetiapine
Interventions
Trazodone
Quetiapine
Pindolol
Blood Collection
Primary outcome measure
Central contacts
Locations
University of Ottawa, Institute of Mental Health Research
Recruiting
Ottawa, Ontario, Canada, K1Z-7K4
Contacts
Sponsor
University of Ottawa
Last update posted
Jul 22, 2011
Last verified
Jul, 2011
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Ottawa on 2011-07-22.